The use of disease-modifying anti-rheumatic drugs for the management of rheumatoid arthritis
Disease and modifying anti-rheumatic drugs (DMARDs) are now considered first-line treatment for rheumatoid arthritis (RA). When initiated early, they have been shown to alter the disease course and reduce joint erosion, reducing or preventing disability and improving quality of life.
ISSN 1833-0991; ISBN 978-1-74249-133-2; Cat. no. PHE 138; 58pp.; Internet only
Additional material
Related publications
Related information
Recommended citation
AIHW 2011. The use of disease-modifying anti-rheumatic drugs for the management of rheumatoid arthritis. Arthritis series no. 16. Cat. no. PHE 138. Canberra: AIHW. Viewed 12 June 2013 <http://www.aihw.gov.au/publication-detail/?id=10737418554>.